- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
You are here
Trial Summary Table
| Trial Name | Phase | Start Date | Sponsors | Countries | Population | Candidate(s) | Status | Expected Completion Date |
|---|---|---|---|---|---|---|---|---|
| HHR Study | Other | Monday, January 31, 2011 | New York University, NIDA | Women, Men, HIV positive | Ongoing | December 2016 | ||
| HOME: a comprehensive HIV testing and linkage package for young MSM of color | Other | Tuesday, January 31, 2012 | NIH, Public Health Foundation Enterprises | United States of America | MSM | Planned | December 2017 | |
| HPTN 052 | III | Tuesday, February 1, 2005 | HPTN, NIAID | United States of America, Botswana, Brazil, India, Kenya, Malawi, South Africa, Thailand, Zimbabwe | Women, Men | Atazanavir, Didanosine, Efavirenz, Lamivudine, Lopinavir/Ritonavir, Nevirapine, Stavudine, TDF, TDF/FTC (Truvada), Zidovudine/Lamivudine | Completed | May 2015 |
| HPTN 065 (TLC-Plus) | Other | Thursday, September 30, 2010 | HIV Prevention Trials Network & NIAID | United States of America | Women, Men, HIV positive | Completed | December 2014 | |
| HPTN 071 (PopART) | Open Label | Saturday, August 31, 2013 | NIAID, NIMH, NIDA, Office of the U.S. Global AIDS Coordinator, Bill & Melinda Gates Foundation, & NIH | South Africa, Zambia | Women, Men, HIV positive | Completed | August 2017 | |
| HPTN 074 | Open Label, III | Sunday, February 1, 2015 | HPTN, NIDA, NIAID | Indonesia, Ukraine, Thailand | HIV positive, Injecting drug users | Completed | June 2018 | |
| HPTN 078 | Other | Monday, June 6, 2016 | NIAID (DAIDS ID: 11995) | United States of America | HIV positive, MSM | Completed | February 2019 | |
| HPTN 094/ INTEGRA | Demo Project, Open Label | Wednesday, June 9, 2021 | NIAID (DAIDS ID: 38715) | United States of America | HIV positive, Injecting drug users, Men, Women | Ongoing | ||
| HPTN 096 | Open Label, Other | Friday, April 1, 2022 | HPTN; DIAID, NAID | HIV positive, MSM | Ongoing | June 2027 | ||
| imPACT | Other | Saturday, March 31, 2012 | University of North Carolina - Chapel Hill, NIH, NIDA | United States of America | Women, Men, HIV positive | Ongoing | October 2014 |